Learn, Analyse & Invest
only with
only with
+91
Download Orca
Capricorn Systems Global Solutions Ltd.
Capricorn Systems
₹ 0.00
0.00 (0.00)%
NSE
BSE
Software & IT Services
Small-cap - With a market cap of ₹32.34 Cr.
| EX-Date | Purpose |
|---|---|
| 25 06 2021 | Audited Results & Quarterly Results |
| 13 08 2021 | Quarterly Results |
| 03 09 2021 | A.G.M. |
| 14 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 28 05 2022 | Audited Results |
| 06 07 2022 | Interalia to consider and approve shifting of registered office of company from one place to another place within local limits amongst other matters |
| 13 08 2022 | Quarterly Results |
| 03 09 2022 | A.G.M. |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 26 05 2023 | Audited Results |
| 12 08 2023 | Quarterly Results |
| 02 09 2023 | Inter alia, to discuss the following, amongst other matters, if any: 1) To convene the 38th Annual General Meeting of the company. 2) Draft Notice for the 38th Annual General Meeting of the Members of the Company |
| 06 10 2023 | Inter alia, to consider the shifting of registered office of company from one place to another place within local limits amongst other matters. |
| 14 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 08 11 2024 | Quarterly Results |
| 23 01 2025 | Quarterly Results |
| 01 03 2025 | Inter alia, to consider and approve:- (1) Initially discuss on various restructuring options |
| 06 03 2025 | Issue Of Warrants & Scheme of Arrangement & Increase in Authorised Capital Inter alia to discuss the following: 1. To consider and approve the increase in the authorized share capital of the Company and subsequent amendment in the Memorandum of Association of the Company; 2. To consider and approve the proposal of fund raising in one or more tranches, inter alia, by issue of Warrants convertible into Equity Shares through Preferential Issue in accordance with the provisions of the Companies Act, 2013, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, from time to time, SEBI Listing Regulations and other applicable law, to such investors, as may be permitted to invest in such issuance of warrants, as deemed appropriate, subject to approval of the shareholders of the Company and receipt of egulatory / statutory approvals. 3. To consider and approve the amalgamation of M/s. Radical Bio-Organics Limited with and into M/s. Capricorn Systems Global Solutions Limited under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013, SEBI Listing Regulations etc. 4. any other item with the permission of the Chairperson. |
| 12 03 2025 | Issue Of Warrants & Amalgamation & Increase in Authorised Capital Inter alia to discuss the following: 1. To consider and approve the increase in the authorized share capital of the Company and subsequent amendment in the Memorandum of Association of the Company; 2. To consider and approve the proposal of fund raising in one or more tranches, inter alia, by issue of Warrants convertible into Equity Shares through Preferential Issue in accordance with the provisions of the Companies Act, 2013, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, from time to time, SEBI Listing Regulations and other applicable law, to such investors, as may be permitted to invest in such issuance of warrants, as deemed appropriate, subject to approval of the shareholders of the Company and receipt of regulatory / statutory approvals. 3. To consider and approve the amalgamation of M/s. Radical Bio-Organics Limited with and into M/s.Capricorn Systems Global Solutions Limited under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013, SEBI Listing Regulations etc. 4. any other item with the permission of the Chairperson. |
| 29 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 10 10 2025 | Right Issue of Equity Shares & Inter alia, the proposal of fund raising by way of issue of equity shares of the Company through a rights issue, and/or other modalities including determination of price thereon subject to such regulatory/ statutory approvals as may be required |
| 16 10 2025 | Right Issue of Equity Shares |
| 14 11 2025 | Quarterly Results |
| 14 02 2026 | Quarterly Results |
| 11 04 2026 | Inter alia, to discuss the following: a. to consider and approve the amalgamation of M/s. Radical Bio-Organics Limited with and into M/s. Capricorn Systems Global Solutions Limited under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013, SEBI Listing Regulations etc. b. to consider any other item with the permission of the Chair. |
News
No News data available
